ARCH — Arch Biopartners Balance Sheet
0.000.00%
Last trade - 00:00- CA$115.34m
- CA$118.56m
- CA$2.12m
Annual balance sheet for Arch Biopartners, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.654 | 0.448 | 0.506 | 0.831 | 0.003 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.061 | 2.2 | 0.087 | 0.297 | 0.899 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.741 | 2.67 | 0.622 | 1.17 | 0.936 |
| Total Assets | 0.741 | 2.67 | 0.622 | 1.17 | 0.936 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.22 | 3.19 | 2.78 | 5.98 | 5.28 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 4.61 | 6.55 | 5.09 | 6.68 | 5.28 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -3.87 | -3.88 | -4.47 | -5.51 | -4.35 |
| Total Liabilities & Shareholders' Equity | 0.741 | 2.67 | 0.622 | 1.17 | 0.936 |
| Total Common Shares Outstanding |